Skip to content

Clinical trials

Phase 2 Carcinoma, Ductal, Breast trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Ductal, Breast Phase: Phase 2 Country / region: United States Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20052
20082
20091
20103
20171
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Active, not recruiting3
Terminated2
Recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
City of Hope Medical Center2
Rutgers, The State University of New Jersey2
Alliance for Clinical Trials in Oncology1
Avelas Biosciences, Inc.1
Case Comprehensive Cancer Center1
Eastern Cooperative Oncology Group1
Memorial Sloan Kettering Cancer Center1
Radiation Therapy Oncology Group1
SWOG Cancer Research Network1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms13
Carcinoma, Ductal, Breast13
Carcinoma, Lobular8
Carcinoma, Intraductal, Noninfiltrating5
Breast Neoplasms, Male4
Inflammatory Breast Neoplasms4
Breast Carcinoma In Situ3

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.